Sponsor study identifier
Secondary identifiers
observational
500
1 country
1
Study Start
February 8, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Primary Completion
January 8, 2035
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 8, 2035
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Background: The National Institute of Neurological Disorders and Stroke (NINDS) often enrolls healthy volunteers in certain studies. These studies allow researchers to look for causes of diseases and disorders by comparing affected people to healthy ones. Prescreening lets volunteers participate in multiple studies without having to repeat the screening tests each time. Having a registry of prescreened volunteers also makes it easier for researchers to reach people willing to participate in their studies. Objective: To create a registry of healthy volunteers who have been prescreened for NINDS research studies. Eligibility: Healthy people aged 18 years and older. Design: Participants will have 1 clinic visit for prescreening. This visit will take about 5 hours. The visit may be spread across 1 to 3 days. Participants will have the following procedures: A physical exam, including height, weight, and vital signs. A review of their medical history and medications. They will also provide personal data such as age, sex, and years of education. An exam of their nervous system. This will include tests of their strength and reflexes, following an object with their eyes, and other tasks. Cognitive tests. These tests will check their memory, attention, and thinking. A magnetic resonance imaging (MRI) scan. They will lie on a table that slides into a cylinder; Magnetic fields will create images of their brain. Handedness. They will complete a questionnaire about what hand they use for most tasks. Participants may remain on the healthy volunteers list for 2 years. If they wish to participate longer, they will need to return to repeat all of the screening tests.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 8, 2035
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 11, 2026
Actual (reported)July 14, 2026
Actual (reported)February 8, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
January 8, 2035
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
January 8, 2035
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
To screen and create a temporary list of volunteers in good health for participation in NINDS studies (Volunteer List) in order to reduce costs, inconvenience to volunteers, and duplication of effort.
From enrollment/consent until withdrawal from the registry or study closure.
Healthy volunteers
Healthy Volunteers
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Eric M Wassermann, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
First Submitted
July 11, 2026
First Posted
July 14, 2026
Study Start
February 8, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Primary Completion
January 8, 2035
EstimatedEstablishment of Biobank of Nasal Epithelium Samples From Healthy Volunteers
Contact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 8, 2035
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
July 14, 2026
Record last verified: 2026-07-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: